These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22332695)

  • 21. Proton pump inhibitors are associated with risk of chronic kidney disease, study finds.
    Wise J
    BMJ; 2016 Jan; 352():i128. PubMed ID: 26759185
    [No Abstract]   [Full Text] [Related]  

  • 22. Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series.
    Mackay JD; Bladon PT
    QJM; 2010 Jun; 103(6):387-95. PubMed ID: 20378675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of proton pump inhibitors and the risk of chronic kidney disease].
    Divisón Garrote JA; Escobar Cervantes C
    Semergen; 2017 Apr; 43(3):230-231. PubMed ID: 27132589
    [No Abstract]   [Full Text] [Related]  

  • 24. [Asymptomatic hypomagnesemic hypoparathyroidism induced by pantoprazol].
    Basterra-Gortari FJ; Goñi Iriarte MJ; Toni García M; Iriarte Beroiz A
    Med Clin (Barc); 2011 Oct; 137(11):524-5. PubMed ID: 21481426
    [No Abstract]   [Full Text] [Related]  

  • 25. Severe hypomagnesemia during long-term treatment with a proton pump inhibitor.
    Regolisti G; Cabassi A; Parenti E; Maggiore U; Fiaccadori E
    Am J Kidney Dis; 2010 Jul; 56(1):168-74. PubMed ID: 20493607
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hypomagnesemia and proton pump inhibitors].
    Fumeaux C; Schmidtko J; Meier P
    Rev Med Suisse; 2012 Apr; 8(336):806-10. PubMed ID: 22574415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gastric polyposis due to treatment with proton pump inhibitors].
    Huguet JM; Ruiz L; Ortí E; Luján M; Sempere J; Medina E
    Gastroenterol Hepatol; 2009 Feb; 32(2):88-91. PubMed ID: 19231680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of proton pump inhibitors increased the risk of hip fracture: a population-based case-control study.
    Chiu HF; Huang YW; Chang CC; Yang CY
    Pharmacoepidemiol Drug Saf; 2010 Nov; 19(11):1131-6. PubMed ID: 20872906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton pump inhibitors and hypomagnesemia: a rare but serious complication.
    Perazella MA
    Kidney Int; 2013 Apr; 83(4):553-6. PubMed ID: 23538697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse Effects Associated With Proton Pump Inhibitors.
    Schoenfeld AJ; Grady D
    JAMA Intern Med; 2016 Feb; 176(2):172-4. PubMed ID: 26751904
    [No Abstract]   [Full Text] [Related]  

  • 31. [Magnesium: the missing link between kidneys and vessels?].
    Tran TA; Jaques D; Ponte B
    Rev Med Suisse; 2016 Feb; 12(507):404-7. PubMed ID: 27039606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is red meat consumption the confounding factor explaining the association between chronic kidney disease and proton pump inhibitors?
    Desbuissons G; Mercadal L
    Nephrol Ther; 2019 Jul; 15(4):191-192. PubMed ID: 31056405
    [No Abstract]   [Full Text] [Related]  

  • 33. Relationship between N-terminal pro-B-type natriuretic peptide plasma levels and renal function evaluated with different formulae in older adult subjects admitted because of dyspnea.
    Fabbian F; De Giorgi A; Portaluppi F; Zuliani G
    Gerontology; 2012; 58(1):50-5. PubMed ID: 21540563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of effect of chronic kidney disease on clopidogrel response with high loading and maintenance doses of clopidogrel after Acute Coronary Syndrome.
    Cuisset T; Frere C; Moro PJ; Quilici J; Pons C; Gaborit B; Camoin L; Morange PE; Bonnet JL; Alessi MC
    Thromb Res; 2010 Nov; 126(5):e400-2. PubMed ID: 20828794
    [No Abstract]   [Full Text] [Related]  

  • 35. Risk of recurrent myocardial infarction with the concomitant use of clopidogrel and proton pump inhibitors.
    Valkhoff VE; 't Jong GW; Van Soest EM; Kuipers EJ; Sturkenboom MC
    Aliment Pharmacol Ther; 2011 Jan; 33(1):77-88. PubMed ID: 21083580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis.
    Del Valle E; Negri AL; Aguirre C; Fradinger E; Zanchetta JR
    Hemodial Int; 2007 Jul; 11(3):315-21. PubMed ID: 17576296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3-hydroxyanthranilic acid is independently associated with monocyte chemoattractant protein-1 (CCL2) and macrophage inflammatory protein-1beta (CCL4) in patients with chronic kidney disease.
    Pawlak K; Kowalewska A; Mysliwiec M; Pawlak D
    Clin Biochem; 2010 Sep; 43(13-14):1101-6. PubMed ID: 20599874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nephrotic syndrome and chronic renal insufficiency associated with essential cryofibrinogenemia.
    Singh A; Gaber LW
    Nephrol Dial Transplant; 2007 Jun; 22(6):1772-5. PubMed ID: 17395660
    [No Abstract]   [Full Text] [Related]  

  • 39. Proton pump inhibitors: a better prescription is needed.
    Khara HS; Pitchumoni CS
    J Clin Gastroenterol; 2009 Jul; 43(6):597-8. PubMed ID: 19384247
    [No Abstract]   [Full Text] [Related]  

  • 40. Physiological similarities and differences between renal aging and chronic renal disease.
    Musso CG; Macías Nuñez JF; Oreopoulos DG
    J Nephrol; 2007; 20(5):586-7. PubMed ID: 17918144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.